These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 8747081)

  • 1. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
    Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of finasteride (Proscar) on the proliferation of cultured epithelial and stromal cells from normal and hyperplastic human prostates.
    Lobaccaro JM; Boudon C; Lechevallier E; Mottet N; Rebillard X; Lumbroso S; Gibelin B; Sultan C
    Cell Mol Biol (Noisy-le-grand); 1996 Jun; 42(4):511-8. PubMed ID: 8828906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate.
    Span PN; Völler MC; Smals AG; Sweep FG; Schalken JA; Feneley MR; Kirby RS
    J Urol; 1999 Jan; 161(1):332-7. PubMed ID: 10037433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin increases 5alpha-reductase activity of human prostate epithelial cells, but not stromal cells.
    Assinder SJ
    Prostate; 2008 Feb; 68(2):115-21. PubMed ID: 18008328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of 5 alpha-reductase isoenzymes in benign prostatic hyperplasia (BPH).
    Rennie PS; Bruchovsky N; McLoughlin MG; Batzold FH; Dunstan-Adams EE
    J Steroid Biochem; 1983 Jul; 19(1A):169-73. PubMed ID: 6193340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activity of 5 alpha-reductase in human hyperplastic prostates].
    Lin Y
    Zhonghua Yi Xue Za Zhi; 1991 May; 71(5):263-5, 20. PubMed ID: 1713809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Messenger RNA levels and enzyme activities of 5 alpha-reductase types 1 and 2 in human benign prostatic hyperplasia (BPH) tissue.
    Shirakawa T; Okada H; Acharya B; Zhang Z; Hinata N; Wada Y; Uji T; Kamidono S; Gotoh A
    Prostate; 2004 Jan; 58(1):33-40. PubMed ID: 14673950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas.
    Bonkhoff H; Stein U; Aumüller G; Remberger K
    Prostate; 1996 Oct; 29(4):261-7. PubMed ID: 8876709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5alpha-reductase inhibitors/finasteride.
    Stoner E
    Prostate Suppl; 1996; 6():82-7. PubMed ID: 8630236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates.
    Bruchovsky N; Rennie PS; Batzold FH; Goldenberg SL; Fletcher T; McLoughlin MG
    J Clin Endocrinol Metab; 1988 Oct; 67(4):806-16. PubMed ID: 2458378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and significance of steroid 5alpha-reductase isoenzymes in benign hyperplastic prostate tissues].
    Ye LF; Zhang YF; Fang ZJ; Ding Q; Yao MS
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1296-9. PubMed ID: 12930680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma.
    Luo J; Dunn TA; Ewing CM; Walsh PC; Isaacs WB
    Prostate; 2003 Oct; 57(2):134-9. PubMed ID: 12949937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [5 alpha-reductase and prostate].
    Lobaccaro JM; Boudon C; Lumbroso S; Lechevallier E; Mottet N; Rebillard X; Sultan C
    Ann Endocrinol (Paris); 1997; 58(5):381-92. PubMed ID: 9685996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
    Mendoza P; Sánchez C; Contreras HR; Vergara J; Acevedo C; Cabezas J; Huidobro C; Noé G; Castellón EA
    Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and molecular evidence for the expression of the two steroid 5 alpha-reductase isozymes in normal and hyperplastic human prostatic cells in culture.
    Berthaut I; Mestayer C; Portois MC; Cussenot O; Mowszowicz I
    Prostate; 1997 Aug; 32(3):155-63. PubMed ID: 9254894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
    Thomas LN; Douglas RC; Vessey JP; Gupta R; Fontaine D; Norman RW; Thompson IM; Troyer DA; Rittmaster RS; Lazier CB
    J Urol; 2003 Nov; 170(5):2019-25. PubMed ID: 14532845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Enzyme inhibition in the drug therapy of benign prostatic hyperplasia].
    Drsata J
    Cas Lek Cesk; 2002 Oct; 141(20):630-5. PubMed ID: 12515038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M; Bartsch W; Thomsen M; Voigt KD
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    World J Urol; 2002 Apr; 19(6):413-25. PubMed ID: 12022710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.